Oncogene – celebrates 20 years of shaping the scientific community and publishing the latest developments in cancer research. Oncogene is published weekly and covers the structure and function of oncogenes.
Free online issue
Volume 28, No 46
19 November 2009
ISSN: 0950-9232
EISSN: 1476-5594
2008 impact factor 7.216*
13/141 Oncology
14/138 Genetics & Heredity
26/157 Cell Biology
29/276 Biochemistry & Molecular Biology
Editor-in-Chief:
Douglas R. Green
*2008 Journal Citation Reports (Thomson Reuters, 2009)
FEATURED ARTICLES
ORIGINAL ARTICLE
Silencing of the NRG1 gene in breast cancer FREEORIGINAL ARTICLE
p68, p72, ER
co-activation and breast cancer
ORIGINAL ARTICLE
Chemosensitivity mediated by miR-140ORIGINAL ARTICLE
Dysregulation of FLIP ubiquitination by Akt in chemoresistant ovarian cancer FREEORIGINAL ARTICLE
RB loss cooperates with discrete oncogenes FREEORIGINAL ARTICLE
c-KIT mutants are oncogenic in melanocytesOncogene News
Breast cancer’s Achilles heel. Reactivating NRG1 in breast tumors may prove crucial in curing the disease. Read how this normally pro-apoptotic gene is silenced in many breast cancers.
Cell deaths remote control. Applying BH3-only proteins affinity for initiating apoptosis could help treat inflammatory diseases. Read how BCL-2 family members like BIK, BAD and PUMA may be crucial in preventing rheumatoid arthritis, heart failure and other diseases in this recent supplement for Oncogene.
Web Focus: Stem Cell Therapy. The vast medical potential and recent advances in embryonic and adult stem cell biology create a further need to better communicate novel findings among the scientific community. Read this multi-journal web focus compiling free articles dedicated to the advancement of stem cell research.
Oncogene Reviews. Mechanizing apoptosis is one of many possible future applications involving PTEN. Read this and other issues of Oncogene Reviews highlighting a broad spectrum of topics including microRNA's, antibody therapies for cancer and FOXO.
Other NPG news
Gene therapy for prostate cancer. Prostate cancer affects one in six men and is the second leading cause of cancer death among men in the US. Gene therapy shows promise as a treatment strategy that can target both localized and metastatic prostate cancer. View this web focus to read more about the field of prostate cancer gene therapy.
Submit your paper to Nature Precedings while your manuscript is under consideration. This archive provides a rapid way to disseminate emerging results and new theories, solicit opinions, and record the provenance of ideas. Register to submit documents now.
-
Research and Reviews
Latest research highlights and reviews from the NPG family of journals
- Non-muscle myosin II takes centre stage in cell adhesion and migration Source: Nature Reviews Molecular Cell Biology
- Reconstruction of the history of anthropogenic CO2 concentrations in the ocean Source: Nature
- Monitoring α4β7 integrin expression on circulating CD4+ T cells as a surrogate marker for tracking intestinal CD4+ T-cell loss in SIV infection - this content is FREE Source: Mucosal Immunology
